Literature DB >> 15251735

Renal cell carcinoma metastatic to the pituitary gland: clinical manifestations and successful treatment with transsphenoidal resection.

I E Marar1, H Kandil, E Kanal, D Marion, M Inman, J A Amico.   

Abstract

OBJECTIVE: To describe two cases of metastatic involvement of the pituitary gland by renal cell carcinoma (RCCA) and review the medical literature regarding this entity.
METHODS: We present two case reports and discuss the published literature to illustrate the clinical findings, radiographic features, and recommended management of RCCA metastatic to the pituitary gland.
RESULTS: During a 12-month period, we encountered two patients, one with visual deficits and both with anterior pituitary dysfunction, who had large sellar lesions that were histologically proved to be RCCA. Both patients were successfully treated with transsphenoidal surgical resection of the lesion, one of whom is alive and well more than 2 years later. A pituitary metastatic tumor is an uncommon complication of RCCA; it may be difficult to diagnose and potentially fatal. Anterior pituitary dysfunction and visual disturbances are more common initial features than is diabetes insipidus, in contrast to pituitary metastatic involvement from other tumors.
CONCLUSION: Transsphenoidal resection is a safe and effective method of treatment of RCCA metastatic to the pituitary gland.

Entities:  

Year:  1998        PMID: 15251735     DOI: 10.4158/EP.4.4.204

Source DB:  PubMed          Journal:  Endocr Pract        ISSN: 1530-891X            Impact factor:   3.443


  2 in total

Review 1.  Clinical and biochemical characteristic features of metastatic cancer to the sella turcica: an analytical review.

Authors:  Ribal Al-Aridi; Katia El Sibai; Pingfu Fu; Mehreen Khan; Warren R Selman; Baha M Arafah
Journal:  Pituitary       Date:  2014-12       Impact factor: 4.107

2.  Symptomatic pituitary metastases from renal cell carcinoma.

Authors:  Thottathil Gopan; Steven A Toms; Richard A Prayson; John H Suh; Amir H Hamrahian; Robert J Weil
Journal:  Pituitary       Date:  2007       Impact factor: 4.107

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.